Fidelity Investments’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $196M | Sell |
9,226,376
-111,847
| -1% | -$2.38M | 0.01% | 827 |
|
|
2025
Q1 | $180M | Buy |
9,338,223
+1,282,853
| +16% | +$24.7M | 0.01% | 832 |
|
|
2024
Q4 | $144M | Sell |
8,055,370
-247,749
| -3% | -$4.42M | 0.01% | 967 |
|
|
2024
Q3 | $182M | Buy |
8,303,119
+737,692
| +10% | +$16.2M | 0.01% | 855 |
|
|
2024
Q2 | $59M | Sell |
7,565,427
-409,104
| -5% | -$3.19M | ﹤0.01% | 1250 |
|
|
2024
Q1 | $33M | Buy |
7,974,531
+7,965,209
| +85,445% | +$33M | ﹤0.01% | 1479 |
|
|
2023
Q4 | $24.3K | Buy |
9,322
+6,233
| +202% | +$16.3K | ﹤0.01% | 3838 |
|
|
2023
Q3 | $5.78K | Buy |
3,089
+2,464
| +394% | +$4.61K | ﹤0.01% | 4295 |
|
|
2023
Q2 | $1.57K | Buy |
+625
| New | +$1.57K | ﹤0.01% | 4647 |
|
|
2022
Q2 | – | Sell |
-729
| Closed | -$2K | – | 5436 |
|
|
2022
Q1 | $2K | Buy |
+729
| New | +$2K | ﹤0.01% | 4703 |
|